UPDATE: Benchmark Raises Price Target on BioClinica to $8

According to Benchmark, BioClinica BIOC price target is raised to $8. Benchmark said that it hosted an investor event at BioClinica's eClinical software headquarters in Audubon, PA on January 13. “We are increasing our price target to $8.00, from $7.00, to reflect a 20x multiple of our unchanged $0.40 EPS forecast this year.” BioClinica closed on Friday at $4.77.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsBenchmark
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!